Holden H - Search Results

1

Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. I. Clinical aspects.

LoBuglio AF, Saleh MN, Lee J, Khazaeli MB, Carrano R, Holden H, Wheeler RH. LoBuglio AF, et al. Among authors: holden h. J Natl Cancer Inst. 1988 Aug 17;80(12):932-6. doi: 10.1093/jnci/80.12.932. J Natl Cancer Inst. 1988. PMID: 3398068

2

Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. II. Pharmacokinetics and immune response.

Khazaeli MB, Saleh MN, Wheeler RH, Huster WJ, Holden H, Carrano R, LoBuglio AF. Khazaeli MB, et al. Among authors: holden h. J Natl Cancer Inst. 1988 Aug 17;80(12):937-42. doi: 10.1093/jnci/80.12.937. J Natl Cancer Inst. 1988. PMID: 3398069

3

In situ Fc receptor-bearing cells in two murine tumors. I. Isolation and identification.

Korn JH, Haskill JS, Holden HT, Radov LA, Ritter FL. Korn JH, et al. Among authors: holden ht. J Natl Cancer Inst. 1978 Jun;60(6):1387-90. doi: 10.1093/jnci/60.6.1387. J Natl Cancer Inst. 1978. PMID: 650702

4

In situ Fc receptor-bearing cells in two murine tumors. II. Role in tumor immunity.

Korn JH, Haskill JS, Holden HT, Radov LA, Ritter FL. Korn JH, et al. Among authors: holden ht. J Natl Cancer Inst. 1978 Jun;60(6):1391-7. doi: 10.1093/jnci/60.6.1391. J Natl Cancer Inst. 1978. PMID: 306442 No abstract available.

5

Correlation between natural and antibody-dependent cell-mediated cytotoxicity against tumor targets in the mouse. I. Distribution of the reactivity.

Santoni A, Herberman RB, Holden HT. Santoni A, et al. Among authors: holden ht. J Natl Cancer Inst. 1979 Jan;62(1):109-16. J Natl Cancer Inst. 1979. PMID: 281565 No abstract available.

6

Correlation between natural and antibody-dependent cell-mediated cytotoxicity against tumor targets in the mouse. II. Characterization of the effector cells.

Santoni A, Herberman RB, Holden HT. Santoni A, et al. Among authors: holden ht. J Natl Cancer Inst. 1979 Oct;63(4):995-1003. J Natl Cancer Inst. 1979. PMID: 384012 Review.

7

Cytotoxicity inhibition assay: cryopreservation and standardization: brief communication.

Oldham RK, Ortaldo JR, Holden HT, Herberman RB. Oldham RK, et al. Among authors: holden ht. J Natl Cancer Inst. 1977 Oct;59(4):1321-3. doi: 10.1093/jnci/59.4.1321. J Natl Cancer Inst. 1977. PMID: 904003

8

Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus.

Herberman RB, Aoki T, Nunn M, Lavrin DH, Soares N, Gazdar A, Holden H, Chang KS. Herberman RB, et al. Among authors: holden h. J Natl Cancer Inst. 1974 Oct;53(4):1103-11. doi: 10.1093/jnci/53.4.1103. J Natl Cancer Inst. 1974. PMID: 4139276 No abstract available.

9

Cellular immunity to murine sarcoma virus-induced tumors as measured by macrophage migration inhibition assays.

Landolfo S, Herberman RB, Holden HT. Landolfo S, et al. Among authors: holden ht. J Natl Cancer Inst. 1977 Dec;59(6):1675-83. doi: 10.1093/jnci/59.6.1675. J Natl Cancer Inst. 1977. PMID: 200758

10

Systemic and in situ natural killer activity in C57BL/6N and CBA/N mice bearing murine sarcoma virus-induced regressor tumors.

Gerson JM, Holden HT, Herberman RB. Gerson JM, et al. Among authors: holden ht. J Natl Cancer Inst. 1980 Nov;65(5):905-7. J Natl Cancer Inst. 1980. PMID: 6253708

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

504 results

Search Page

Filters